Lalach Harvey 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Feb 23, 2011
Insider Transaction Report
Form 4
Lalach Harvey
DirectorPresident CEO CFO
Transactions
- Sale
common stock
2011-02-18$3.75/sh−3,000$11,250→ 597,000 total - Sale
common stock
2011-02-18$3.74/sh−1,628$6,089→ 595,372 total
Holdings
- 600,000
common stock
- 150,000
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying) - 200,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying)